In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Mallinckrodt acquires skin substitute company Stratatech

Executive Summary

Mallinckrodt PLC acquired privately held regenerative medicine company Stratatech Corp. (cell-based skin substitute). Stratatech's progenitor keratinocyte (the predominant cell type in the skin's outermost layer, the epidermis) tissue-engineering technology produces living tissues designed to mimic human skin and promote tissue regeneration.
Deal Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Acquisition of Private Biotech

Related Companies

Advertisement
UsernamePublicRestriction

Register